Cargando…
Two cases of EBV infection preceding lymphoma
Infection of lymphocytes with the Epstein-Barr virus (EBV) is a well-documented risk factor for developing lymphoma. The incidence of EBV positivity in lymphoma depends on the subtype and can range from 10% in diffuse large B-cell lymphoma (DLBCL) to 100% in endemic Burkitt lymphoma (BL), (Shannon-L...
Autores principales: | Saal, Jonas, Aboudan, Busher, Brossart, Peter, Heine, Annkristin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470712/ https://www.ncbi.nlm.nih.gov/pubmed/35732965 http://dx.doi.org/10.1007/s00432-022-04145-4 |
Ejemplares similares
-
Implementing combinatorial immunotherapeutic regimens against cancer: The concept of immunological conditioning
por: Wolf, Dominik, et al.
Publicado: (2014) -
Clinical and immunological effects of mRNA vaccines in malignant diseases
por: Heine, Annkristin, et al.
Publicado: (2021) -
Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah’s Witness patient
por: Schlaweck, Sebastian, et al.
Publicado: (2021) -
Spoilt for choice: different immunosuppressive potential of anaplastic lymphoma kinase inhibitors for non small cell lung cancer
por: Heine, Annkristin, et al.
Publicado: (2023) -
EBV-related lymphoma after long-term daratumumab treatment: a case report
por: Verpoorte-Botden, Ilse P. G., et al.
Publicado: (2020)